Form 8-K - Current report:
SEC Accession No. 0001206774-22-001630
Filing Date
2022-06-30
Accepted
2022-06-30 17:15:27
Documents
12
Period of Report
2022-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron4078581-8k.htm   iXBRL 8-K 31055
  Complete submission text file 0001206774-22-001630.txt   204192

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gern-20220630.xsd EX-101.SCH 2950
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220630_pre.xml EX-101.PRE 22353
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220630_lab.xml EX-101.LAB 34240
6 EXTRACTED XBRL INSTANCE DOCUMENT geron4078581-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 221058745
SIC: 2834 Pharmaceutical Preparations